Syros Pharmaceuticals, Inc.(NasdaqGS:SYRS) dropped from S&P Global BMI Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.84 USD | -6.56% | -7.74% | -25.03% |
Mar. 27 | Health Care Jumps as Upward Momentum Builds -- Health Care Roundup | DJ |
Mar. 27 | Transcript : Syros Pharmaceuticals, Inc., 2023 Earnings Call, Mar 27, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.03% | 152M | |
+9.16% | 45.97B | |
+54.54% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock Syros Pharmaceuticals, Inc. - Nasdaq
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals, Inc.(NasdaqGS: SYRS) dropped from S&P Global BMI Index